DNAJC6
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
94423single nucleotide variantNM_001256864.1(DNAJC6):c.801-2A>G398122404MedGen:C3809811,OMIM:61552816538571065385710AG
94423single nucleotide variantNM_001256864.1(DNAJC6):c.801-2A>G398122404MedGen:C3809811,OMIM:61552816585139365851393AG
94424single nucleotide variantNM_001256865.1(DNAJC6):c.2200C>T (p.Gln734Ter)398122405MedGen:C3809811,OMIM:61552816587173565871735CT
94424single nucleotide variantNM_001256865.1(DNAJC6):c.2200C>T (p.Gln734Ter)398122405MedGen:C3809811,OMIM:61552816540605265406052CT
220990single nucleotide variantNM_001256865.1(DNAJC6):c.244C>T (p.Arg82Ter)864622011MedGen:C0376358,OMIM:176807,SNOMED CT:C037635816536610765366107CT
220990single nucleotide variantNM_001256865.1(DNAJC6):c.244C>T (p.Arg82Ter)864622011MedGen:C0376358,OMIM:176807,SNOMED CT:C037635816583179065831790CT
247505single nucleotide variantNM_001256865.1(DNAJC6):c.2569A>G (p.Arg857Gly)879255630MedGen:CN23781916541139465411394AG
247505single nucleotide variantNM_001256865.1(DNAJC6):c.2569A>G (p.Arg857Gly)879255630MedGen:CN23781916587707765877077AG
247506single nucleotide variantNM_001256865.1(DNAJC6):c.2013A>T (p.Thr671=)879255554MedGen:CN23781916586755965867559AT
247506single nucleotide variantNM_001256865.1(DNAJC6):c.2013A>T (p.Thr671=)879255554MedGen:CN23781916540187665401876AT
260693single nucleotide variantNM_001256865.1(DNAJC6):c.2326C>T (p.Gln776Ter)886039854MedGen:C3809811,OMIM:61552816587436865874368CT
260693single nucleotide variantNM_001256865.1(DNAJC6):c.2326C>T (p.Gln776Ter)886039854MedGen:C3809811,OMIM:61552816540868565408685CT
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
165782658rs4916041TArs49160411ETOPOSIDEXANTHENES|ANTINEOPLASTIC AGENTS, PHYTOGENIC|RESAZURIN|OXAZINESDrug response to EtoposideNANAT,AintronGWASdb_drug
165801562rs6588131CArs65881311ETOPOSIDEXANTHENES|ANTINEOPLASTIC AGENTS, PHYTOGENIC|RESAZURIN|OXAZINESDrug response to EtoposideNANACintronGWASdb_drug
165808281rs2375699GArs23756991ETOPOSIDEXANTHENES|ANTINEOPLASTIC AGENTS, PHYTOGENIC|RESAZURIN|OXAZINESDrug response to EtoposideNANACintronGWASdb_drug
165861798rs11208645AGrs112086452.76E-05TOPIRAMATE|FRUCTOSEANTICONVULSANTSCognitive impairment induced by topiramateHPOID:0100543DOID:1561AintronGWASdb_drug
165732242rs2477786CTrs24777862.10E-24Progranulin levelsHPOID:0011018DOID:9255CintronGWASdb_trait
165732242rs2477786CTrs24777862.10E-24Myocardial infarctionHPOID:0001658DOID:5844CintronGWASdb_trait
165732242rs2477786CTrs24777864.70E-06Urinary metabolitesHPOID:0000079DOID:557CintronGWASdb_trait
165782658rs4916041TArs49160411Drug response to EtoposideNANAT,AintronGWASdb_trait
165785372rs2281855GArs22818555.25E-05Attention deficit hyperactivity disorderHPOID:0007018DOID:1094TintronGWASdb_trait
165801562rs6588131CArs65881311Drug response to EtoposideNANACintronGWASdb_trait
165808281rs2375699GArs23756991Drug response to EtoposideNANACintronGWASdb_trait
165815659rs1413885CTrs14138853.00E-07Anticoagulant levelsHPOID:0011111DOID:866TintronGWASdb_trait
165832352rs7541003ATrs75410035.96E-04Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
165858088rs6588144TCrs65881446.85E-04Smoking initiationHPOID:0000707DOID:0050742TintronGWASdb_trait
165859108rs4332387GCrs43323874.37E-04Smoking initiationHPOID:0000707DOID:0050742CintronGWASdb_trait
165861798rs11208645AGrs112086452.76E-05Cognitive impairment induced by topiramateHPOID:0100543DOID:1561AintronGWASdb_trait
165869274rs4655762CTrs46557621.90E-04Alzheimer's diseaseHPOID:0002511DOID:10652CintronGWASdb_trait
165869489rs2148682TCrs21486823.03E-04Alzheimer's diseaseHPOID:0002511DOID:10652TintronGWASdb_trait
165873605rs11208646ATrs112086462.47E-04Alzheimer's diseaseHPOID:0002511DOID:10652AintronGWASdb_trait
165879252rs10493377AGrs104933777.81E-05AtopyHPOID:0001047DOID:0060056GUTR-3GWASdb_trait
Disease associated variation - GWAS Central
Study NameSource Marker AccessionChromosomeMarker StartMarker StopAllelesGene SectionP-value-log(p-value)
GWAS of prostate cancerrs157086816583060865830608intronic0.9794060.00903723975121941
GWAS of prostate cancerrs228185516578537265785372intronic0.9740160.0114339089790462
GWAS of prostate cancerrs1088954616585175965851759intronic0.9455450.0243177975575655
GWAS of prostate cancerrs1208673816580741265807412intronic0.9224640.0350505735769474
GWAS of prostate cancerrs237569916580828165808281intronic0.9041840.04374318229751151
GWAS of prostate cancerrs658813816583836665838366intronic0.8848640.053123473469698305
GWAS of prostate cancerrs667796816577670265776702intronic0.818790.086827470078095
GWAS of prostate cancerrs214868216586948965869489intronic0.787150.103942500214092
GWAS of prostate cancerrs1049337716587925265879252UTR30.7398450.130859256884739
GWAS of prostate cancerrs132560716575106065751060intronic0.7319150.135539352239994
GWAS of prostate cancerrs491569116586751965867519exonic0.5533440.25700479481848
GWAS of prostate cancerrs50169116574382765743827intronic0.516310.287089463365016
GWAS of prostate cancerrs1120864516586179865861798intronic0.4788440.319805949996547
GWAS of prostate cancerrs141492716575973165759731intronic0.4672290.33047020924088905
GWAS of prostate cancerrs298590216576264065762640intronic0.4305510.36597539773711396
GWAS of prostate cancerrs1049337416578323165783231intronic0.337420.471829178912832
GWAS of prostate cancerrs1049337516584465465844654intronic0.3337810.476538388537559
GWAS of prostate cancerrs754462716574591965745919intronic0.1718180.7649313405561039
GWAS of prostate cancerrs1078917916577231565772315intronic0.1566890.804961491131823
GWAS of prostate cancerrs381851316587403765874037intronic0.0882991.05404421484759
GWAS of prostate cancerrs91319916587106265871062intronic0.0340811.46748767070961
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000116675.15 DNAJC6 608375